Biogen Idec Brazil

Biogen Idec Inc. (NASDAQ: BIIB) is a global biotechnology leader with products in oncology, neurology and immunology. Biogen Idec is committed to transforming scientific discoveries into advances and health care. The company's include the discovery, research, development and biomanufacturing of medicine and a global commercial infrastructure.

Biogen Idec pursues the creativity of science with passion and discipline. For over 25 years, the company has grown through the discovery, development and commercialization of innovative products themselves and through strategic alliances.

Scientific excellence that achieves new standards of care drives the company's work. Currently, more than twenty products are in clinical development to meet a number of important medical needs.

Biogen Idec has affiliates in Brazil, Canada, Australia, Japan and throughout Europe, including the international headquarters in Zug, Switzerland. The company currently employs approximately 3,600 people worldwide.

In Brazil, Biogen Idec is focused on the Multiple Sclerosis market, as an expert company in the disease, and is responsible for organizing World MS Day activities in the country.

Type:	EXECUTIVE
Address:	Av. Doutor Cardoso de Melo, 1.184, 17º andar Vila Olimpia São Paulo – SP - Brasil Cep: 04548-004
Website:	http://www.biogenidec.com.br/
Phone:	+55 11 3568-3400